These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 16697503

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K, Kodama S, Umemoto S, Nomi N, Hirano T, Suzuki M.
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [Abstract] [Full Text] [Related]

  • 4. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
    Abe N, Kodama S, Hirano T, Eto M, Suzuki M.
    Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
    [Abstract] [Full Text] [Related]

  • 5. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, Green BA.
    Vaccine; 2004 Sep 03; 22(25-26):3449-56. PubMed ID: 15308371
    [Abstract] [Full Text] [Related]

  • 6. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A, Kodama S, Hirano T, Suzuki M, Mogi G.
    Infect Immun; 2001 May 03; 69(5):2964-71. PubMed ID: 11292713
    [Abstract] [Full Text] [Related]

  • 7. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S, Hirano T, Noda K, Umemoto S, Suzuki M.
    Vaccine; 2011 Feb 24; 29(10):1881-90. PubMed ID: 21237276
    [Abstract] [Full Text] [Related]

  • 8. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
    McMahon M, Murphy TF, Kyd J, Thanavala Y.
    Vaccine; 2005 May 20; 23(27):3590-6. PubMed ID: 15855018
    [Abstract] [Full Text] [Related]

  • 9. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A, Kodama S, Sabirova N, Mogi G, Suzuki M.
    Vaccine; 2004 Aug 13; 22(23-24):3112-21. PubMed ID: 15297063
    [Abstract] [Full Text] [Related]

  • 10. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM, Becker PD, Guzmán CA, Grinstein S.
    J Infect Dis; 2004 Apr 01; 189(7):1304-12. PubMed ID: 15031801
    [Abstract] [Full Text] [Related]

  • 11. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx.
    Noda K, Kodama S, Umemoto S, Abe N, Hirano T, Suzuki M.
    Vaccine; 2010 Jul 12; 28(31):5068-74. PubMed ID: 20478344
    [Abstract] [Full Text] [Related]

  • 12. Study on specific mucosal immunity by intranasal immunization of outer membrane protein P6 of Haemophilus influenzae with cholera toxin B subunit.
    Hotomi M, Yokoyama M, Kuki K, Togawa A, Yamanaka N.
    Acta Otolaryngol Suppl; 1996 Jul 12; 523():150-2. PubMed ID: 9082765
    [Abstract] [Full Text] [Related]

  • 13. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S, Hirano T, Noda K, Abe N, Suzuki M.
    Vaccine; 2010 Mar 16; 28(13):2510-6. PubMed ID: 20117272
    [Abstract] [Full Text] [Related]

  • 14. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear.
    Kodama S, Hirano T, Abe N, Suzuki M.
    Acta Otolaryngol; 2007 Aug 16; 127(8):809-15. PubMed ID: 17762989
    [Abstract] [Full Text] [Related]

  • 15. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin.
    Hotomi M, Saito T, Yamanaka N.
    Vaccine; 1998 Dec 16; 16(20):1950-6. PubMed ID: 9796049
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae.
    Hotomi M, Yamanaka N, Shimada J, Suzumoto M, Ikeda Y, Sakai A, Arai J, Green B.
    Int J Pediatr Otorhinolaryngol; 2002 Sep 02; 65(2):109-16. PubMed ID: 12176180
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.